Valtorcitabine (dihydrochloride)
Valtorcitabine dihydrochloride is a prodrug of L-deoxycytidine and also is an HBV inhibitor[1].
Product Specifications
CAS Number
359689-54-6
UNSPSC
12352005
Target
HBV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/valtorcitabine-dihydrochloride.html
Solubility
10 mM in DMSO
Smiles
OC[C@@H]1O[C@H](N(C=CC(N)=N2)C2=O)C[C@H]1OC([C@@H](N)C(C)C)=O.Cl.Cl
Molecular Formula
C14H24Cl2N4O5
Molecular Weight
399.27
References & Citations
[1]Kim KH, et al. Discovery and development of anti-HBV agents and their resistance. Molecules. 2010 Aug 27;15 (9) :5878-908.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
